Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division

Vivani Medical, Inc., an innovative, clinical-stage biopharmaceutical company that develops novel, long-term therapeutic implants, announced the filing of a Registration Statement on Form S-1 with the U.S. Securities and Exchange Commission for the proposed initial public offering of Cortigent, Inc.